Calendar Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange 23:00:00 05/10/2023 BST 5-day change 1st Jan Change
0.175 CAD +45.83% Intraday chart for Mydecine Innovations Group Inc. +29.63% -61.11%

Chart calendar Mydecine Innovations Group Inc.

5e47d58f8d4ceb349c.kdhcTw2sQLNVGV8GxHBR4OgPz2ifzNvXT_nyw1BFlKg.wLMuN1_NNYUwIXJQrTsJq45f_DDqiY2WfIO1ugUU58rh6QN9Ofh05w1IPA~6c1fcdf8f9aa435a23818b6644cdb9d4

Upcoming events on Mydecine Innovations Group Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
04/07/2024 Annual General Meeting
11/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Mydecine Innovations Group Inc.

15/11/2023 09:49 Q3 2023 Earnings Release
15/08/2023 01:32 Q2 2023 Earnings Release
03/07/2023 Extraordinary Shareholders Meeting
16/05/2023 21:01 Q1 2023 Earnings Release
04/05/2023 Annual General Meeting
01/04/2023 01:21 Q4 2022 Earnings Release
16/08/2022 02:46 Interim 2022 Earnings Release
20/07/2022 Annual General Meeting
17/05/2022 02:28 Q1 2022 Earnings Release
01/04/2022 01:53 FY 2021 Earnings Release
27/03/2022 Maxim Growth Conference
05/12/2021 H.C. Wainwright Psychedelics Conference
11/11/2021 00:30 Horizons Veterans & Families Forum - Panel
07/11/2021 Microdose Wonderland Miami Meeting - One on One
22/09/2021 20:00 M-Vest Maxim Group Advances in Mental Health Virtual Conference - Panel
22/09/2021 15:00 Maxim Group and M-Vest Advances in Mental Health Virtual Conference - Panel
21/09/2021 Maxim Group and M-Vest Advances in Mental Health Virtual Conference
21/09/2021 18:15 Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
20/09/2021 19:00 Annual General Meeting
13/09/2021 12:00 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2020 2021
Net sales
Million CAD
Released
Forecast
Spread
0,06


0,01
0,06
-88.3%
EBITDA
Million CAD
Released
Forecast
Spread
0,00


-25,0
-23,5
-6.5%
EBIT
Million CAD
Released
Forecast
Spread
0,00


-28,7
-26,1
-9.97%
Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
0,00


-28,9
-22,7
-27.22%
Net income
Million CAD
Released
Forecast
Spread
-26,9


-28,9
-22,7
-27.22%
EPS
CAD
Released
Forecast
Spread
0,00


-6,00
-4,75
-26.32%
Announcement Date30/04/2131/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,04
-99.82%
-0,01
0,09
-115.32%
0,00
0,30
-



Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



Net income
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



EPS
CAD
Released
Forecast
Spread
-1,00
-0,50
-100%
-2,00
-1,00
-100%
-1,20
-1,00
-20%
-0,35


Announcement Date15/11/2131/03/2216/05/2215/08/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. MYCO Stock
  5. Calendar Mydecine Innovations Group Inc.